Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.
Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 31 - 40 of 177 |
Scientist, Investigative Sciences
Cambridge, Massachusetts
Overview We are seeking a scientist to join our Investigative Sciences team to help advance our RNAi therapeutics platform by elucidating mechanisms of toxicity and de-risking siRNA ligand candidates through hypothesis-driven, translational...
7h
| Job Type | Full Time |
Scientist, Research (Targeted Delivery)
Cambridge, Massachusetts
Overview The Research Department at Alnylam is seeking a Scientist to join a growing team responsible for advancing RNAi therapeutics into the future, by opening up targeted delivery to all tissues. The successful candidate will have a work...
7h
| Job Type | Full Time |
Principal Scientist, Advanced In Vitro Platforms
Cambridge, Massachusetts
Overview We are seeking an accomplished and motivated Principal Scientist to lead innovation in advanced in vitro modeling to enable RNAi discovery and development. In this role, you will be responsible for designing, validating, and implem...
7h
| Job Type | Full Time |
Cambridge, Massachusetts
Overview The Research Department at Alnylam is seeking a highly motivated and creative scientific leader to join our Next Wave, Target Discovery and Validation team. Our mission is to discover novel genetically informed targets and experime...
7h
| Job Type | Full Time |
Associate Director, Omnichannel Operations (US TTR)
Cambridge, Massachusetts
Overview The Associate Director, Omnichannel Operations (US TTR) is responsible for end-to-end operational delivery of omnichannel execution for TTR brands in the United States. This role ensures that U.S. omnichannel activity-across email,...
7h
| Job Type | Full Time |
Associate Director, Case Management Vendor Oversight
Cambridge, Massachusetts
Overview The Associate Director, Case Management Vendor Oversight (CMVO), Global Safety Operations is responsible for implementing processes and procedures to support the oversight of ICSR processing activities as well as maintaining regula...
7h
| Job Type | Full Time |
Supervisor, Manufacturing-Second Shift
Cambridge, Massachusetts
Overview The Supervisor, Manufacturing provides direct and detailed GMP manufacturing oversight of clinical drug substance manufacturing at Alnylam's Norton manufacturing site. The Supervisor is responsible for management of Manufacturing t...
7h
| Job Type | Full Time |
Associate Director, Antibody Development
Cambridge, Massachusetts
Overview: The Associate Director, Antibody Development will lead CMC strategy and execution for antibody and antibody-conjugate programs from sequence handoff through IND and early clinical supply. This role requires strong hands-on experie...
7h
| Job Type | Full Time |
Associate Director, Biostatistics
Cambridge, Massachusetts
Overview: The role is responsible for statistical activities in support of Medical Affairs, including post approval value evidence generation, secondary publications, post marketing study design and study protocol development, analysis and ...
7h
| Job Type | Full Time |
Cambridge, Massachusetts
Overview The Director,Epidemiologyis responsible for representing the Epidemiology function at Alnylam providing expertise, strategic vision, and oversight of epidemiology and real-world evidence (RWE) activities in support of all clinical ...
7h
| Job Type | Full Time |